OSE Immunotherapeutics SA
LSE:0RAD
OSE Immunotherapeutics SA
LSE:0RAD
Price:
3.15
EUR
2.94%
Market Closed
Market Cap:
€237.9k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
OSE Immunotherapeutics SA
LSE:0RAD
|
FR |
|
H
|
HomeChoice International PLC
JSE:HIL
|
MT |
|
N
|
Norfolk Southern Corp
XMUN:NFS
|
US |
|
F
|
Fairfax Financial Holdings Ltd
F:FFX
|
CA |
|
N
|
NVIDIA Corp
DUS:NVD
|
US |
|
Hamborner REIT AG
OTC:HMBRF
|
DE |
|
R
|
Rhoen Klinikum AG
XHAM:RHK
|
DE |
|
Viscofan SA
OTC:VSCFF
|
ES |
|
O
|
Oil States International Inc
F:OI2
|
US |
|
T
|
Teck Resources Ltd
XMUN:TEKB
|
CA |
|
L
|
Lamar Advertising Co
XMUN:6LA
|
US |
|
O
|
Olin Corp
SWB:OLN
|
US |
|
S
|
Swiss Prime Site AG
DUS:SU1N
|
CH |
|
A
|
American International Group Inc
XMUN:AINN
|
US |
|
Hoya Corp
TSE:7741
|
JP |
|
Covestro AG
OTC:CVVTF
|
DE |
Wall St Price Targets
0RAD Price Targets Summary
OSE Immunotherapeutics SA
OSE Immunotherapeutics SA
Wall Street analysts forecast 0RAD stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 0RAD is 13.63 EUR with a low forecast of 8.39 EUR and a high forecast of 22.32 EUR.
Lowest Forecast
Price Target
8.39
EUR
166% Upside
Average Forecast
Price Target
13.63
EUR
333% Upside
Highest Forecast
Price Target
22.32
EUR
609% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RAD's stock price target?
Price Target
13.63
EUR
13.63
EUR
According to Wall Street analysts, the average 1-year price target for 0RAD is 13.63 EUR with a low forecast of 8.39 EUR and a high forecast of 22.32 EUR.
What is the Revenue forecast for OSE Immunotherapeutics SA?
Projected CAGR
58%
58%
The compound annual growth rate for Revenue over the next 4 years is 58%.
